ATRC
AtriCure, Inc.
Overview
AtriCure designs and manufactures surgical devices for treating atrial fibrillation, managing left atrial appendage, and controlling post-operative pain. The company sells ablation systems, appendage exclusion devices, and cryoablation probes to hospitals and surgical centers through direct sales and distributors in the U.S., Europe, Australia, and Canada.
AtriCure, Inc is a Healthcare company operating in Medical Instruments & Supplies with a $1.46B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0614 Q&A exchanges
- Q4 FY2025Earnings2026-02-1715 Q&A exchanges
- Q3 FY2025Earnings2025-10-2915 Q&A exchanges
- Q2 FY2025Earnings2025-07-2917 Q&A exchanges
- Q1 FY2025Earnings2025-04-2920 Q&A exchanges
- Q4 FY2024Earnings2025-02-1232 Q&A exchanges
- Q3 FY2024Earnings2024-10-2915 Q&A exchanges
- Q2 FY2024Earnings2024-07-3119 Q&A exchanges
- Q1 FY2024Earnings2024-05-0124 Q&A exchanges
- Q4 FY2023Earnings2024-02-1529 Q&A exchanges
- Q3 FY2023Earnings2023-11-0123 Q&A exchanges
- Q2 FY2023Earnings2023-07-2523 Q&A exchanges
- Q1 FY2023Earnings2023-05-0222 Q&A exchanges
- Q4 FY2022Earnings2023-02-2124 Q&A exchanges
- Q3 FY2022Earnings2022-11-0116 Q&A exchanges
- Q2 FY2022Earnings2022-08-0325 Q&A exchanges
- Q1 FY2022Earnings2022-05-0320 Q&A exchanges
- Q4 FY2021Earnings2022-02-1517 Q&A exchanges
- Q3 FY2021Earnings2021-11-0322 Q&A exchanges
- Q2 FY2021Earnings2021-08-0722 Q&A exchanges
- Q1 FY2021Earnings2021-04-2716 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $0.03—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $0.03 | — | — | — | — | EODHD |
Source: EODHD. ATRC reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ATRC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.11 | $3.69 | -15.7% | +0.5% | +0.4% |
| Q4 FY2026 | $3.19 | $3.61 | -11.7% | +0.9% | +3.8% |
| Q3 FY2026 | $2.83 | $3.85 | -26.4% | +3.1% | +2.9% |
| Q2 FY2026 | $2.85 | $3.61 | -21.1% | -4.3% | -2.7% |
| Q1 FY2025 | $3.15 | $3.85 | -18.1% | +4.2% | +5.7% |
| Q4 FY2025 | $3.09 | $3.71 | -16.7% | +1.7% | +1.0% |
| Q3 FY2025 | $3.16 | $3.91 | -19.2% | +4.0% | +2.1% |
| Q2 FY2025 | $2.95 | $3.94 | -25.2% | +1.8% | +1.9% |
| Q1 FY2024 | $3.27 | $3.70 | -11.7% | -0.7% | -3.2% |
| Q4 FY2024 | $3.34 | $3.99 | -16.2% | -5.5% | -7.8% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Michael H CarrelCEO1 yr 3 mo21 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
- Angela L WirickCFO3 mo14 callsCurrentSample
CFO since 2026 • 1/2 beats (50%) • last guidance cut Q1 FY2026
- Douglas J SeithCOO1 yr 3 mono recorded callsCurrentSample
COO since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
- Salvatore PriviteraChief Technical Officer1 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last call held guidance Q2 FY2026
- Karl S DahlquistChief Legal Officer1 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
- Vinayak DoraiswamyChief Scientific Officer1 yr 1 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ATRC.
$ curl https://api.spokenalpha.com/v1/companies/ATRCFAQ
Frequently asked about ATRC
Where can I find AtriCure, Inc.'s (ATRC) earnings call transcripts?
Spoken Alpha indexes ATRC's earnings call transcripts at https://spokenalpha.com/companies/ATRC. Each call links to attributed speakers and parsed analyst Q&A. AtriCure, Inc.'s own investor relations page is at https://atricure.com/investors.
When was AtriCure, Inc.'s most recent earnings call?
AtriCure, Inc. (ATRC) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.
What sector is ATRC in?
AtriCure, Inc. (ATRC) operates in the Healthcare sector (Medical Instruments & Supplies industry).